Investigating Generics

INVESTIGATING GENERICS: FDA Records Show Drug Companies Are Skipping Safety Checks

The most common violations cited during FDA inspections involve companies failing to test ingredients, review manufacturing records, or follow basic quality control procedures

Mar 30, 2026

INVESTIGATING GENERICS: After a MedShadow Investigation, Researchers Take a Closer Look at Opioid Recalls

A newly published academic analysis finds widespread quality failures and gaps in recall notices that could affect patient safety

Feb 23, 2026

INVESTIGATING GENERICS: Push for Safer Generic Drugs Picks Up Speed on Capitol Hill

A Senate proposal to add manufacturing details to drug labels is part of a broader push for supply-chain transparency, testing, and oversight

Feb 5, 2026

INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain

An investigation by MedShadow found that certain types of opioid medications are more likely to be recalled, and many are produced in facilities repeatedly cited for poor quality control.

Nov 3, 2025

INVESTIGATING GENERICS: Two-Thirds of Americans Would Pay More for Safer Drugs

A MedShadow/Kantar survey shows most Americans support independent testing, and one in three say their generics don’t always work the same

Sep 15, 2025

INVESTIGATING GENERICS: Senate Probes Drug Manufacturing Failures and Risks to U.S. Supply

At a Sept. 17th hearing, experts testified that cost-cutting, overseas labs, and weak oversight are putting Americans — especially older Americans — at risk

Sep 23, 2025

INVESTIGATING GENERICS: Real People Share Their Struggles With Generic ADHD Medications

From strange side effects to lost scholarships, people say low-quality ADHD generics have upended their lives, confirming what studies and doctors are finding, too.

Sep 29, 2025

INVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD Meds

Clinicians across the country say patients are reporting their medication feels less effective — or they develop new side effects — after a generic switch

Sep 3, 2025

INVESTIGATING GENERICS: The Trouble With Generic Vyvanse

Fourteen companies now make generic lisdexamfetamine, an ADHD medication, but some patients say the pills don’t work, and two manufacturers have already issued recalls

Jul 28, 2025

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis

Generic drugs dominate prescriptions in the U.S. But manufacturing shortcuts and overseas oversight gaps may be putting millions at risk.

Jun 19, 2025

INVESTIGATING GENERICS: They Say Their ADHD Meds Aren’t Working. They’re Not Imagining It

Shortages, recalls, and drug variability have left people living with ADHD feeling unheard and unwell, even when they take their meds exactly as prescribed

May 30, 2025

FDA Fails in Lab Inspections of Thousands of Drug Manufacturers

An AP investigation revealed that the FDA has missed inspections for 2,000 labs since 2019, despite its own five-year mandate.

Nov 13, 2024

INVESTIGATING GENERICS: Hundreds Of Drugs Remain On The Market After Fraudulent Trials

Generic forms of common drugs such as Lipitor and Viagra are some of the many drugs whose safety is being questioned.

Oct 28, 2024

Open Letter to the FDA: You’re Protecting the Wrong People

The FDA knows that hundreds of drugs were approved based on potentially fraudulent testing. So why are these medications still on the shelves?

Jul 23, 2024